A61K 31/46
8-azabicyclo [3.2.1] octane
Official title: 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
A61K31/46 (8-azabicyclo [3.2.1] octane) appears on 864 US grants and 1,505 published applications in this corpus.
Search patents in A61K- Granted patents
- 864
- Published applications
- 1,505
- Assignees
- 647
- Inventors
- 2,542
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 12 | 0 |
| 1991 | 10 | 0 |
| 1992 | 5 | 0 |
| 1993 | 9 | 0 |
| 1994 | 10 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 11 | 0 |
| 1998 | 31 | 0 |
| 1999 | 16 | 0 |
| 2000 | 7 | 0 |
| 2001 | 10 | 3 |
| 2002 | 16 | 30 |
| 2003 | 13 | 40 |
| 2004 | 10 | 42 |
| 2005 | 8 | 48 |
| 2006 | 10 | 45 |
| 2007 | 14 | 40 |
| 2008 | 18 | 39 |
| 2009 | 9 | 35 |
| 2010 | 22 | 58 |
| 2011 | 12 | 60 |
| 2012 | 24 | 53 |
| 2013 | 26 | 66 |
| 2014 | 41 | 79 |
| 2015 | 50 | 94 |
| 2016 | 57 | 77 |
| 2017 | 45 | 95 |
| 2018 | 41 | 68 |
| 2019 | 41 | 82 |
| 2020 | 46 | 71 |
| 2021 | 39 | 76 |
| 2022 | 42 | 85 |
| 2023 | 26 | 60 |
| 2024 | 39 | 65 |
| 2025 | 28 | 53 |
| 2026 | 24 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Patch for alleviating or treating symptoms of neurodegenerative disease29 Sep 2026US 12,746,232 B2Nobelpharma AB
- Compositions and methods for the treatment of motion sickness and emesis18 Aug 2026US 12,708,628 B2Repurposed Therapeutics, Inc.
- Calcineurin inhibitors of the setron family for the treatment of hearing loss11 Aug 2026US 12,702,671 B2Sensorion
- Methods of treating hepatic encephalopathy4 Aug 2026US 12,697,326 B2Salix Pharmaceuticals, Inc.
- Compositions and methods for the treatment of liver disorders14 Jul 2026US 12,678,430 B2Viking Therapeutics, Inc.
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Diffusion resistance layer for analyte sensors8 Oct 2026US 2026/0309670 A1DexCom, Inc.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Compounds and methods for modulating splicing24 Sep 2026US 2026/0285853 A1Remix Therapeutics Inc.
- Compound for treatment of female sexual dysfunction10 Sep 2026US 2026/0263443 A1Initiator Pharma A/S
Most cited
By later US patents
- Controlled release hydrocodone formulations336US 6,733,783 B2Euro-Celtique S. A. · 2004
- Bandage for transdermally administering scopolamine to prevent nausea299US 4,031,894 AAlza Corporation · 1977
- Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches224US 6,432,986 B12002
- Method for directed intranasal administration of a composition196US 7,799,337 B22010
- Method and therapeutic system for providing chemotherapy transdermally185US 4,060,084 AAlza Corporation · 1977